203
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE “MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
ANALYSIS OF FACTORS INFLUENCING THE MARKET OF ANTI-
OSTEOPOROTIC DRUGS
Yusupo a Z.K.
Saipo a D.T.
Tashken Pha maceu ical Ins i u e, Tashken ci y, Republic o Uzbekis an
e-mail: [email p o ec ed]
h ps://doi.o g/10.5281/zenodo.17332772
Rele ance: os eopo osis is a sys emic diso de cha ac e ized by educed bone mass, s eng h,
and mic oa chi ec u e, leading o inc eased bone agili y. I poses a signi ican medical and socio-
economic h ea . Acco ding o es ima es, in he 21s cen u y, app oxima ely 250 million people
wo ldwide a e a ec ed by os eopo osis. The disease is ch onic and signi ican ly impac s he quali y
o li e (QoL) due o pain, limi a ions in physical ac i i y and social li e, as well as changes in men al
heal h.
Se e al challenges exis in p o iding ca e o pa ien s wi h os eopo o ic ac u es. These can be
di ided in o wo main g oups: he i s is pa ien s’ pe sonal a i udes owa d he diagnosis and
ea men o os eopo osis, and he second is he lack o su icien p oac i i y among heal hca e
p o essionals in diagnosing os eopo osis, p esc ibing an i-os eopo o ic he apy, and moni o ing i s
e ec i eness. Recen s udies indica e ha e en a e ac u es occu , pa ien s o en do no pay
adequa e a en ion o os eopo osis diagnosis o ea men . I is p ojec ed ha by 2050, mo e han 50%
o os eopo o ic ac u es wo ldwide will occu in Asia, making he issue pa icula ly ele an o
Uzbekis an, whe e he popula ion and li e expec ancy a e inc easing. Cu en ly, ensu ing he supply
o an i-os eopo o ic d ugs o pa ien s wi h os eopo osis emains a p essing issue. The lack o
comp ehensi e s udies on he an i-os eopo o ic d ug ma ke in Uzbekis an c ea es se e al challenges
in mee ing he popula ion’s needs and demands o hese medica ions.
Pu pose o he s udy: he p ima y objec i e o his s udy is o iden i y he ac o s in luencing
he an i-os eopo o ic d ug ma ke h ough analysis, scien i ically e alua e hei in e ela ionships, and
o ecas u u e ma ke de elopmen ends. Addi ionally, he s udy aims o imp o e heal hca e
policies and p o ide p ac ical ecommenda ions o ma ke s akeholde s.
Ma e ials and me hods: in his s udy, compa a i e analysis and s a is ical me hods we e
employed o iden i y gene al ac o s a ec ing he consump ion o an i-os eopo o ic d ugs, based on
da a om he Na ional S a is ics Commi ee o he Republic o Uzbekis an and he Ins i u e o Heal h
and S a egic De elopmen . The ob ained da a we e p ocessed using Mic oso Excel so wa e.
Resul s: he s udy analyzed he p e alence o os eopo osis in Uzbekis an and he ac o s
in luencing he an i-os eopo o ic d ug ma ke . Be ween 2016 and 2024, he numbe o os eopo osis
cases in he coun y inc eased om 5,383 o 10,516, e lec ing a 95% o e all g ow h end. Acco ding
o CAGR calcula ions, he annual g ow h a e a e aged 9%, wi h he highes a es obse ed in he
Republic o Ka akalpaks an (46%), Na oi (46%), and Andijan (45%) egions. A Pea son co ela ion
analysis showed a posi i e co ela ion ( = 0.61) be ween popula ion g ow h and os eopo osis cases
ac oss he coun y, wi h he highes co ela ion in Kho ezm egion ( = 0.98). U baniza ion analysis
e ealed ha in 2024, 53.5% o pa ien s we e u ban esiden s, while 46.5% we e u al esiden s, and
women accoun ed o 53% o cases. Limi ed diagnos ic capabili ies (0.16 densi ome e s pe 1 million
people, wi h only 33 ce i ied de ices since 2014) we e ound o hinde ea ly de ec ion o he disease
and nega i ely impac ma ke demand.
204
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE “MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
Conclusions: pha maceu ical and medical ac o s we e iden i ied as ha ing he mos signi ican
impac on he ma ke ing en i onmen o he an i-os eopo o ic d ug ma ke . Addi ionally, economic,
demog aphic, and poli ical ac o s we e no ed as in luencing he dynamics o he d ug ma ke .
